12:00 AM
 | 
Nov 08, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

NBI-34060: Completed Phase II trial

Neurocrine Biosciences Inc. (NBIX), San Diego, Calif.
Product: NBI-34060
Business: Neurological
Therapeutic category: Receptor...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >